← board
SDEV
distress 6/10 · elevated risk$1.16+1%today-99% from 52w high
Revenue
pre-revenue
Liquidity
$18M
Runway
2.1 yrs
Shares 1y
+366%
Price & events
-95.8% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.9%
1D
-6.5%
1W
+0.9%
1M
-10.1%
3M
-95.1%
6M
-46.8%
1Y
-83.5%
2Y
-100.0%
5Y
-100.0%
All
Overview
- Market Cap
- $31.45M
- Volume
- 7.00K
- 52 Week Range
- $1.01 – $95.80
- Total Shares
- 27.12M
- Float Shares
- 7.16M
- Short %
- 6.13%
- % Held by Insiders
- 92.40%
- % Held by Institutions
- 3.65%
- RVOL
- 0.01x
- Beta
- 0.11
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.